Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Triple-negative breast cancer (TNBC) is aggressive and lacks targeted therapies.
• Cancerous inhibitor of protein phosphatase 2A (Cip2a) is an oncogene targeting PP2A tumor suppressor activity.
• Cip2a is a potential therapeutic target in TNBC, but its roles in progression need further elucidation.

Purpose of the Study:

• To investigate the functional roles of Cip2a in TNBC progression.
• To identify novel targets of Cip2a in TNBC.
• To elucidate the regulatory mechanisms involving Cip2a and microRNAs in TNBC.

Main Methods:

• MiRNA microarray analysis in TNBC cell lines.
• Investigation of the transcriptional regulation of miR-301a by Cip2a and E2F1.
• Analysis of miR-301a expression in TNBC tissues.
• Assessment of the impact of miR-301a on TNBC cell proliferation and invasion.
• Exploration of the feedback mechanism between miR-301a and Cip2a via ERK/CREB signaling.

Main Results:

• MiR-301a was identified as a novel target of Cip2a in TNBC.
• Cip2a upregulates E2F1, which transcriptionally activates miR-301a by binding to the SKA2 promoter.
• MiR-301a levels are significantly increased in TNBC tissues.
• Upregulated miR-301a mediates Cip2a-induced proliferation and invasion in TNBC cells.
• MiR-301a feedback promotes Cip2a expression through ERK/CREB signaling activation.

Conclusions:

• A novel auto-regulatory feedback loop between Cip2a and miR-301a was discovered in TNBC.
• This Cip2a-miR-301a feedback loop plays a critical role in promoting TNBC progression.
• Targeting this feedback loop may offer a new therapeutic strategy for TNBC.